Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Transplant of pig tissue may reduce stroke size and damage


A tiny capsule containing tissue that secretes a cocktail of brain-nourishing neurotrophic factors may one day help reduce the damage and disability of stroke, according to research published in the September issue of Stroke.

Choroid plexus tissue has innate roles in developing and protecting the brain and when additional tissue is transplanted into an animal model of stroke, it reduces stroke size by about 65 percent, Medical College of Georgia researchers report. "What we have seen is the reduction of the size of the stroke in the brain, and the animals that received the transplant showed functional recovery in motor as well as neurological function," said Dr. Cesario V. Borlongan, MCG neuroscientist and first author on the paper.

The study is an important step in moving the potential treatment to clinical trials because the porcine choroid plexus tissue also could be used in humans, Dr. Borlongan said. The cells of the pig choroid plexus are similar in size and function to human cells and pig brain tissue has been used in humans to treat Parkinson’s disease.

For the study, researchers put the pig tissue into biocompatible microcapsules before transplanting them into the rat stroke model. To objectively assess its effectiveness, they compared the results to an empty capsule as well as choroid plexus tissue without the capsule and no treatment. "We have seen in this study that choroid plexus alone, without any capsule, also can reduce stroke damage," said Dr. Borlongan. But they also found increased inflammation when the capsules – designed by LCTBioPharma, Inc., in Providence, R.I., a subsidiary of Living Cell Technologies based in New Zealand and Australia – were not used.

The capsules are designed to allow molecules, such as protective neurotrophic factors, to escape and keep out inflammatory factors that could trigger an immune response and rejection. And they could one day hold more than choroid plexus. "There are different therapies we can combine with this encapsulated therapy, including other substances such as stem cells to help replace brain cells that are lost," Dr. Borlongan said. "We are excited about the potential therapeutic benefits of the choroid plexus but we are moving cautiously toward the idea of using this approach in humans."

Dr. Borlongan published a similar study showing the benefit of rat-to-rat transplants in the May 2004 issue of NeuroReport. He also presented the rat studies as well as early findings on the pig-to-rat transplant studies at the May meeting of the American Society for Neural Transplantation and Repair.

For the Stroke paper, he completed parallel studies in culture that showed brain cells exposed to media collected from the encapsulated choroid plexus survived oxygen deprivation. Now he’s looking long-term at how the encapsulated versus "naked" tissue is tolerated in his animal model. Non-human primate studies will be needed as well before human trials can begin.

One obvious challenge of turning the laboratory findings into an actual new therapy is that the reparative benefits of choroid plexus likely work best immediately after a stroke; right now the Food and Drug Administration typically doesn’t allow invasive procedures immediately after a stroke unless patients are hemorrhaging and need surgery to stop bleeding. The only FDA-approved drug therapy to date in the hours immediately following a stroke resulting from a blood clot is intravenous infusion of the clot-dissolving drug, TPA. Invasive procedures can be used only for chronic stroke, patients who are severely sick, debilitated and not responding, Dr. Borlongan says.

That means any clinical trials likely would start with these chronic patients, who may also benefit. "We want to show first that it’s safe and second that it’s feasible, that when you transplant these cells into a patient, they won’t be rejected and the patient won’t show any detrimental side effects," Dr. Borlongan says, estimating that such studies are likely two years away.

Toni Baker | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>